Laverock Therapeutics secures an additional £6.5m in seed funding, bringing its total to £20m, led by Calculus Capital to enhance its innovative cancer therapies.
Amount Raised
£6.5 Million
Round Type
Seed
LondonBiotechnologyInvestors
Description
Laverock Therapeutics has expanded its seed funding to a total of £20m through an extension of approximately £6.5m. This round was led by Calculus Capital, with involvement from Eli Lilly, Mercia Ventures, Eos Advisory, Maven Capital Partners, and new investor Norcliffe Capital. The funds will support the optimization of preclinical programmes targeting haematological and solid tumours. The CEO stated this investment will advance their early-stage pipeline and foster strategic partnerships.
Quick answer
Laverock Therapeutics raised £6.5 Million in a Seed round, dated June 30, 2025. Investors: Mercia Ventures, Eli Lilly And Company, Eos Advisory, Maven Capital Partners, Norcliffe Capital and Calculus Capital. Laverock Therapeutics is based in London, England, United Kingdom.
- How much did Laverock Therapeutics raise?
- Laverock Therapeutics raised £6.5 Million in a Seed round on June 30, 2025.
- Who invested in Laverock Therapeutics?
- Mercia Ventures, Eli Lilly And Company, Eos Advisory, Maven Capital Partners, Norcliffe Capital and Calculus Capital are named as investors in this round.
- What does Laverock Therapeutics do?
- Laverock Therapeutics is a gene-silencing company with a uniquely powerful technology harnessing the cell’s natural gene regulatory mechanisms to develop programmable advanced therapies.
- Where is Laverock Therapeutics based and how big is it?
- Laverock Therapeutics is based in London, England, United Kingdom.
- Who are the decision-makers at Laverock Therapeutics?
- Fundz holds 2 contacts at Laverock Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Laverock Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- MyndTec raised $100K on August 14, 2025.
- Valthos raised $27M on August 14, 2025.
- Ignitedata (Delaware) raised an undisclosed amount (Series A) on August 14, 2025.
- Better Medicine raised $1.2M (Pre-Seed) on August 14, 2025.
- Superluminal Medicines raised $5M on August 14, 2025.
- X4 Pharmaceuticals raised $85M on August 13, 2025.
Who to call at Laverock Therapeutics, and when
A new round usually means Laverock Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Laverock Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Laverock Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Laverock Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Laverock Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Laverock Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.